(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALDOA mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate increases expression ISO RGD:30308195 6480464 epigallocatechin gallate results in increased expression of ALDOA protein CTD PMID:31195006 1,10-phenanthroline increases expression ISO RGD:30308195 6480464 1, 10-phenanthroline results in increased expression of ALDOA mRNA CTD PMID:19502547 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of ALDOA mRNA CTD PMID:17522070 14-Deoxy-11,12-didehydroandrographolide decreases expression ISO RGD:30308195 6480464 14-deoxy-11, 12-didehydroandrographolide results in decreased expression of ALDOA mRNA CTD PMID:22101062 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ALDOA mRNA CTD PMID:17557909 , PMID:19400957 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ALDOA mRNA CTD PMID:17522070 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of ALDOA mRNA CTD PMID:32145629 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one increases expression ISO RGD:30308195 6480464 Metribolone results in increased expression of ALDOA mRNA CTD PMID:17010196 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of ALDOA mRNA CTD PMID:34747641 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19954255 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ALDOA mRNA CTD PMID:21346803 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ALDOA protein CTD PMID:34915118 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:30308195 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALDOA mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:30308195 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ALDOA mRNA CTD PMID:31121516 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of ALDOA mRNA CTD PMID:21346803 4-hydroxynon-2-enal affects binding ISO RGD:30308195 6480464 ALDOA protein binds to 4-hydroxy-2-nonenal CTD PMID:20043646 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ALDOA mRNA CTD PMID:36843608 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:22248470 acetamide increases expression EXP 6480464 acetamide results in increased expression of ALDOA mRNA CTD PMID:31881176 acetylsalicylic acid decreases expression ISO RGD:30308195 6480464 Aspirin results in decreased expression of ALDOA mRNA CTD PMID:15928584 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of ALDOA mRNA CTD PMID:28959563 aflatoxin B1 increases methylation ISO RGD:30308195 6480464 Aflatoxin B1 results in increased methylation of ALDOA gene CTD PMID:27153756 all-trans-retinoic acid multiple interactions ISO RGD:30308195 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ALDOA mRNA CTD PMID:15894607 all-trans-retinoic acid increases expression ISO RGD:30308195 6480464 Tretinoin results in increased expression of ALDOA mRNA CTD PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ALDOA mRNA CTD PMID:16483693 ampicillin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein CTD PMID:30545405 antimycin A increases expression ISO RGD:30308195 6480464 Antimycin A results in increased expression of ALDOA mRNA CTD PMID:33512557 aristolochic acid A decreases expression ISO RGD:30308195 6480464 aristolochic acid I results in decreased expression of ALDOA mRNA CTD PMID:33212167 arotinoid acid multiple interactions ISO RGD:30308195 6480464 [4-(2-(5 more ... CTD PMID:34480604 arsane increases methylation ISO RGD:30308195 6480464 Arsenic results in increased methylation of ALDOA promoter CTD PMID:21291286 arsenic atom increases methylation ISO RGD:30308195 6480464 Arsenic results in increased methylation of ALDOA promoter CTD PMID:21291286 arsenite(3-) multiple interactions ISO RGD:30308195 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ALDOA protein] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:30308195 6480464 Arsenic Trioxide results in decreased expression of ALDOA protein CTD PMID:15894607 arsenous acid multiple interactions ISO RGD:30308195 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ALDOA mRNA CTD PMID:15894607 atrazine increases expression ISO RGD:30308195 6480464 Atrazine results in increased expression of ALDOA mRNA CTD PMID:22378314 azoxystrobin increases expression ISO RGD:30308195 6480464 azoxystrobin results in increased expression of ALDOA mRNA CTD PMID:33512557 beauvericin decreases expression ISO RGD:30308195 6480464 beauvericin results in decreased expression of ALDOA mRNA CTD PMID:29203277 benzo[a]pyrene increases methylation ISO RGD:30308195 6480464 Benzo(a)pyrene results in increased methylation of ALDOA promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:30308195 6480464 Benzo(a)pyrene results in increased expression of ALDOA protein CTD PMID:17292933 bexarotene increases expression EXP 6480464 Bexarotene results in increased expression of ALDOA mRNA CTD PMID:16648578 bis(2-chloroethyl) sulfide affects expression EXP 6480464 Mustard Gas affects the expression of ALDOA mRNA CTD PMID:15651846 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of ALDOA mRNA CTD PMID:21318169 bis(2-ethylhexyl) phthalate increases expression ISO RGD:30308195 6480464 Diethylhexyl Phthalate results in increased expression of ALDOA mRNA CTD PMID:31163220 bisphenol A multiple interactions ISO RGD:30308195 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALDOA mRNA CTD PMID:28628672 bisphenol A affects expression ISO RGD:30308195 6480464 bisphenol A affects the expression of ALDOA mRNA CTD PMID:30903817 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ALDOA mRNA CTD PMID:25181051 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ALDOA mRNA CTD PMID:18180321 more ... Bisphenol B increases expression ISO RGD:30308195 6480464 bisphenol B results in increased expression of ALDOA protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:30308195 6480464 bisphenol F results in increased expression of ALDOA protein CTD PMID:34186270 butan-1-ol multiple interactions ISO RGD:30308195 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ALDOA mRNA CTD PMID:29432896 cadmium atom multiple interactions ISO RGD:30308195 6480464 Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of ALDOA mRNA] CTD PMID:10866824 cadmium dichloride increases expression ISO RGD:30308195 6480464 Cadmium Chloride results in increased expression of ALDOA mRNA CTD PMID:25596134 caffeine decreases phosphorylation ISO RGD:30308195 6480464 Caffeine results in decreased phosphorylation of ALDOA protein CTD PMID:35688186 calcidiol decreases expression EXP 6480464 Calcifediol deficiency results in decreased expression of ALDOA mRNA CTD PMID:17293106 carbamazepine affects expression ISO RGD:30308195 6480464 Carbamazepine affects the expression of ALDOA mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:30308195 6480464 Nanotubes, Carbon affects the expression of ALDOA protein CTD PMID:22001959 cefaloridine affects expression EXP 6480464 Cephaloridine affects the expression of ALDOA mRNA CTD PMID:18172885 CGP 52608 multiple interactions ISO RGD:30308195 6480464 CGP 52608 promotes the reaction [RORA protein binds to ALDOA gene] CTD PMID:28238834 CHIR 99021 multiple interactions ISO RGD:30308195 6480464 [4-(2-(5 more ... CTD PMID:34480604 chloroacetaldehyde increases expression ISO RGD:30308195 6480464 chloroacetaldehyde results in increased expression of ALDOA mRNA CTD PMID:25596134 chloroform increases expression EXP 6480464 Chloroform results in increased expression of ALDOA mRNA CTD PMID:17522070 chloropicrin decreases expression ISO RGD:30308195 6480464 chloropicrin results in decreased expression of ALDOA mRNA CTD PMID:28476498 chloropicrin increases expression ISO RGD:30308195 6480464 chloropicrin results in increased expression of ALDOA mRNA CTD PMID:26352163 chlorpromazine increases expression EXP 6480464 Chlorpromazine results in increased expression of ALDOA mRNA CTD PMID:25596134 cidofovir anhydrous increases expression ISO RGD:30308195 6480464 Cidofovir results in increased expression of ALDOA mRNA CTD PMID:25596134 cisplatin increases expression ISO RGD:30308195 6480464 Cisplatin results in increased expression of ALDOA mRNA CTD PMID:25596134 clodronic acid increases expression ISO RGD:30308195 6480464 Clodronic Acid results in increased expression of ALDOA mRNA CTD PMID:25596134 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of ALDOA mRNA CTD PMID:21318169 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALDOA mRNA CTD PMID:17602206 clozapine increases expression EXP 6480464 Clozapine results in increased expression of ALDOA mRNA CTD PMID:15860345 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of ALDOA mRNA, cobaltous chloride results in increased expression of ALDOA protein CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:30308195 6480464 cobaltous chloride results in increased expression of ALDOA mRNA CTD PMID:17553155 more ... cobalt dichloride multiple interactions ISO RGD:30308195 6480464 L-4F peptide inhibits the reaction [cobaltous chloride results in increased expression of ALDOA mRNA], zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ALDOA mRNA] CTD PMID:22202117 , PMID:22537771 cobalt(2+) sulfate increases expression ISO RGD:30308195 6480464 cobalt sulfate results in increased expression of ALDOA mRNA CTD PMID:19502547 copper(II) chloride increases expression ISO RGD:30308195 6480464 cupric chloride results in increased expression of ALDOA mRNA CTD PMID:17211630 cortisol multiple interactions ISO RGD:30308195 6480464 [4-(2-(5 more ... CTD PMID:34480604 crocidolite asbestos increases expression ISO RGD:30308195 6480464 Asbestos, Crocidolite results in increased expression of ALDOA protein CTD PMID:29553831 CU-O LINKAGE decreases expression ISO RGD:30308195 6480464 cupric oxide results in decreased expression of ALDOA protein CTD PMID:25470785 curcumin decreases expression ISO RGD:30308195 6480464 Curcumin results in decreased expression of ALDOA mRNA CTD PMID:16880289 cyclosporin A increases expression ISO RGD:30308195 6480464 Cyclosporine results in increased expression of ALDOA mRNA CTD PMID:25596134 cyclosporin A decreases expression ISO RGD:30308195 6480464 Cyclosporine results in decreased expression of ALDOA mRNA CTD PMID:21163907 more ... decabromodiphenyl ether decreases expression ISO RGD:30308195 6480464 decabromobiphenyl ether results in decreased expression of ALDOA protein CTD PMID:31675489 dexamethasone multiple interactions ISO RGD:30308195 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALDOA mRNA CTD PMID:28628672 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of ALDOA mRNA CTD PMID:17522070 diarsenic trioxide multiple interactions ISO RGD:30308195 6480464 [Tretinoin co-treated with Arsenic Trioxide] results in increased expression of ALDOA mRNA CTD PMID:15894607 diarsenic trioxide decreases expression ISO RGD:30308195 6480464 Arsenic Trioxide results in decreased expression of ALDOA protein CTD PMID:15894607 diazinon increases methylation ISO RGD:30308195 6480464 Diazinon results in increased methylation of ALDOA gene CTD PMID:22964155 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ALDOA mRNA CTD PMID:17379624 , PMID:21266533 diethyl maleate affects expression ISO RGD:30308195 6480464 diethyl maleate affects the expression of ALDOA mRNA CTD PMID:34480604 dioxygen increases expression ISO RGD:30308195 6480464 Oxygen deficiency results in increased expression of ALDOA mRNA CTD PMID:10866824 more ... dioxygen multiple interactions ISO RGD:30308195 6480464 Cadmium inhibits the reaction [Oxygen deficiency results in increased expression of ALDOA mRNA], HIF1A protein alternative form inhibits the reaction [Oxygen deficiency results in increased expression of ALDOA mRNA] CTD PMID:10866824 , PMID:11739637 dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate increases expression ISO RGD:30308195 6480464 Antimony Potassium Tartrate results in increased expression of ALDOA mRNA CTD PMID:28713220 dopamine increases expression ISO RGD:30308195 6480464 Dopamine results in increased expression of ALDOA protein CTD PMID:24675778 elemental selenium increases expression ISO RGD:30308195 6480464 Selenium results in increased expression of ALDOA mRNA CTD PMID:19244175 endosulfan decreases expression ISO RGD:30308195 6480464 Endosulfan results in decreased expression of ALDOA mRNA CTD PMID:26615145 enzyme inhibitor multiple interactions ISO RGD:30308195 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ALDOA protein CTD PMID:23301498 ethanol increases expression EXP 6480464 Ethanol results in increased expression of ALDOA mRNA CTD PMID:17920746 ethanol multiple interactions ISO RGD:30308195 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in increased expression of ALDOA mRNA CTD PMID:29432896 ethyl methanesulfonate decreases expression ISO RGD:30308195 6480464 Ethyl Methanesulfonate results in decreased expression of ALDOA mRNA CTD PMID:23649840 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of ALDOA mRNA CTD PMID:25596134 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of ALDOA protein CTD PMID:33656234 flutamide increases expression EXP 6480464 Flutamide results in increased expression of ALDOA mRNA CTD PMID:24136188 furan increases expression EXP 6480464 furan results in increased expression of ALDOA mRNA CTD PMID:25539665 gentamycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein CTD PMID:30545405 glafenine increases expression EXP 6480464 Glafenine results in increased expression of ALDOA mRNA CTD PMID:24136188 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of ALDOA mRNA CTD PMID:15860345 ibuprofen increases expression ISO RGD:30308195 6480464 Ibuprofen results in increased expression of ALDOA mRNA CTD PMID:25596134 ifosfamide increases expression ISO RGD:30308195 6480464 Ifosfamide results in increased expression of ALDOA mRNA CTD PMID:25596134 indometacin multiple interactions ISO RGD:30308195 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of ALDOA mRNA CTD PMID:28628672 isoflavones multiple interactions EXP 6480464 [ENNG co-treated with Isoflavones] results in increased expression of ALDOA protein CTD PMID:22248470 ivermectin decreases expression ISO RGD:30308195 6480464 Ivermectin results in decreased expression of ALDOA protein CTD PMID:32959892 L-ascorbic acid multiple interactions ISO RGD:30308195 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ALDOA mRNA CTD PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:30308195 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ALDOA mRNA CTD PMID:34480604 lead(0) affects expression ISO RGD:30308195 6480464 Lead affects the expression of ALDOA mRNA CTD PMID:28903495 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ALDOA mRNA CTD PMID:16415329 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of ALDOA mRNA CTD PMID:22281203 metformin increases expression EXP 6480464 Metformin results in increased expression of ALDOA mRNA CTD PMID:25596134 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of ALDOA mRNA CTD PMID:16393664 , PMID:28935588 methotrexate decreases expression ISO RGD:30308195 6480464 Methotrexate results in decreased expression of ALDOA protein CTD PMID:24736981 methyl methanesulfonate decreases expression ISO RGD:30308195 6480464 Methyl Methanesulfonate results in decreased expression of ALDOA mRNA CTD PMID:23649840 metronidazole multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein CTD PMID:30545405 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of ALDOA mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALDOA mRNA, [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ALDOA mRNA CTD PMID:17602206 , PMID:28943392 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ALDOA mRNA CTD PMID:16415329 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of ALDOA mRNA CTD PMID:24136188 neomycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein CTD PMID:30545405 nitrofurantoin increases expression EXP 6480464 Nitrofurantoin results in increased expression of ALDOA mRNA, Nitrofurantoin results in increased expression of ALDOA protein CTD PMID:11841787 obeticholic acid decreases expression ISO RGD:30308195 6480464 obeticholic acid results in decreased expression of ALDOA mRNA CTD PMID:27939613 okadaic acid decreases expression ISO RGD:30308195 6480464 Okadaic Acid results in decreased expression of ALDOA protein CTD PMID:19397276 ozone increases phosphorylation EXP 6480464 Ozone results in increased phosphorylation of ALDOA protein CTD PMID:33146391 ozone increases expression EXP 6480464 Ozone results in increased expression of ALDOA mRNA CTD PMID:25838073 , PMID:35737395 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ALDOA protein CTD PMID:15800402 perfluorooctane-1-sulfonic acid increases expression ISO RGD:30308195 6480464 perfluorooctane sulfonic acid results in increased expression of ALDOA mRNA CTD PMID:27153767 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ALDOA mRNA CTD PMID:19162173 , PMID:21318169 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of ALDOA mRNA CTD PMID:15215175 phorone increases expression EXP 6480464 phorone results in increased expression of ALDOA mRNA, phorone results in increased expression of ALDOA protein CTD PMID:11841787 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ALDOA mRNA CTD PMID:19162173 , PMID:21318169 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of ALDOA protein CTD PMID:18095365 quercetin increases expression ISO RGD:30308195 6480464 Quercetin results in increased expression of ALDOA protein CTD PMID:17292933 quinidine increases expression EXP 6480464 Quinidine results in increased expression of ALDOA mRNA CTD PMID:17522070 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of ALDOA mRNA CTD PMID:16415329 S-butyl-DL-homocysteine (S,R)-sulfoximine increases expression EXP 6480464 Buthionine Sulfoximine results in increased expression of ALDOA mRNA, Buthionine Sulfoximine results in increased expression of ALDOA protein CTD PMID:11841787 , PMID:23736079 sarin decreases expression ISO RGD:30308195 6480464 Sarin results in decreased expression of ALDOA mRNA CTD PMID:19522546 SB 431542 multiple interactions ISO RGD:30308195 6480464 [LDN 193189 co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with EGF protein co-treated with FGF2 protein] results in decreased expression of ALDOA mRNA CTD PMID:34480604 selenium atom increases expression ISO RGD:30308195 6480464 Selenium results in increased expression of ALDOA mRNA CTD PMID:19244175 silicon dioxide increases secretion ISO RGD:30308195 6480464 Silicon Dioxide analog results in increased secretion of ALDOA protein CTD PMID:25895662 sodium arsenite increases expression ISO RGD:30308195 6480464 sodium arsenite results in increased expression of ALDOA mRNA, sodium arsenite results in increased expression of ALDOA protein CTD PMID:15899475 , PMID:28713220 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ALDOA protein CTD PMID:29459688 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of ALDOA mRNA CTD PMID:25993096 sunitinib increases expression ISO RGD:30308195 6480464 Sunitinib results in increased expression of ALDOA mRNA CTD PMID:31533062 tamoxifen increases expression EXP 6480464 Tamoxifen results in increased expression of ALDOA mRNA CTD PMID:19400957 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of ALDOA mRNA CTD PMID:17522070 , PMID:31150632 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of ALDOA mRNA] CTD PMID:31150632 tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of ALDOA mRNA CTD PMID:17522070 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of ALDOA protein CTD PMID:35544339 thifluzamide increases expression ISO RGD:30308195 6480464 thifluzamide results in increased expression of ALDOA mRNA CTD PMID:33512557 thimerosal decreases expression ISO RGD:30308195 6480464 Thimerosal results in decreased expression of ALDOA mRNA CTD PMID:27188386 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of ALDOA mRNA CTD PMID:28943392 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of ALDOA mRNA CTD PMID:23411599 trichostatin A decreases expression ISO RGD:30308195 6480464 trichostatin A results in decreased expression of ALDOA mRNA CTD PMID:27188386 trichostatin A increases expression ISO RGD:30308195 6480464 trichostatin A results in increased expression of ALDOA mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:30308195 6480464 Triclosan results in decreased expression of ALDOA mRNA CTD PMID:30510588 triphenylstannane decreases expression ISO RGD:30308195 6480464 triphenyltin analog results in decreased expression of ALDOA protein CTD PMID:31634547 troglitazone increases expression EXP 6480464 Troglitazone results in increased expression of ALDOA mRNA CTD PMID:25596134 valproic acid decreases expression ISO RGD:30308195 6480464 Valproic Acid results in decreased expression of ALDOA mRNA CTD PMID:23179753 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ALDOA mRNA CTD PMID:21318169 valproic acid increases methylation ISO RGD:30308195 6480464 Valproic Acid results in increased methylation of ALDOA gene CTD PMID:29154799 vancomycin multiple interactions EXP 6480464 [Ampicillin co-treated with Neomycin co-treated with Gentamicins co-treated with Metronidazole co-treated with Vancomycin] results in increased expression of ALDOA protein CTD PMID:30545405 vitamin E increases expression ISO RGD:30308195 6480464 Vitamin E results in increased expression of ALDOA mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:30308195 6480464 Vorinostat results in decreased expression of ALDOA mRNA CTD PMID:27188386 XAV939 multiple interactions ISO RGD:30308195 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of ALDOA mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of ALDOA mRNA CTD PMID:34480604 Yessotoxin increases expression ISO RGD:30308195 6480464 yessotoxin analog results in increased expression of ALDOA mRNA CTD PMID:30679557 zinc atom affects binding ISO RGD:30308195 6480464 ALDOA protein binds to Zinc CTD PMID:14534351 zinc dichloride multiple interactions ISO RGD:30308195 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of ALDOA mRNA] CTD PMID:22202117 zinc(0) affects binding ISO RGD:30308195 6480464 ALDOA protein binds to Zinc CTD PMID:14534351
